false
OasisLMS
Skip Navigation Links
Publications
JTO
CRR
ILCN
Menu
Publications
JTO
CRR
ILCN
Hamburger Menu
Catalog
JTO Clinical and Research Reports, August 2022, Vo ...
JTO Clinical and Research Reports, August 2022, Volume 3, Issue 8
Journal | English | 2022
Create Account
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
Editorials
Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (
RET
Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC
Original Articles:
Racial and Ethnic Trends and Disparities in NSCLC
Association Between
EGFR
and
ALK
Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC
Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities
Case Reports
Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With
BAP1
Germline Mutation: A Case Report
Two Uncomplicated Pregnancies on Alectinib in a Woman With Metastatic
ALK
-Rearranged NSCLC: A Case Report
Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report
Distinct NSCLC
EGFR
Variants in a Family With Li-Fraumeni Syndrome: Case Report
Brief Reports
Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes
Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced
ALK
-Positive NSCLC
About JTO Clinical and Research Reports
JTO Clinical and Research Reports
is the official open access journal of the
International Association for the Study of Lung Cancer
. It aims to complement the
Journal of Thoracic Oncology
by offering authors a gold open access publication option and publishing the following article types in particular:
Phase I trials
Well performed single-arm phase II trials
Subset analyses of published trials
Impactful retrospective Studies
Database analysis
Large institutional series
High-quality case reports
Region-specific clinical trials
Subspecialty thoracic oncology studies
Selected high-quality meeting reports
As an open access journal with no subscription charges,
JTO CRR
requires authors to pay a
fee
to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
×
JTO Clinical and Research Reports, August 2022, Volume 3, Issue 8 Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English